Nimesil (Nimesulide)

Nimesulide, the active ingredient in Nimesil, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a 100 mg oral granules for suspension for oral use. It provides analgesic and antipyretic effects for mild to moderate pain, fever and inflammatory conditions such as osteoarthritis, rheumatoid arthritis and primary dysmenorrhea in adult patients.

GNH USA supplies Nimesil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured for the EU market and meets European regulatory standards and is distributed under strict quality controls.

Nimesulide is an NSAID that reduces inflammation and pain by inhibiting cyclo‑oxygenase enzymes. - Mild to moderate pain: provides analgesic relief in acute and chronic pain states. - Fever: lowers elevated body temperature associated with infection or inflammation. - Osteoarthritis: alleviates joint pain and stiffness in degenerative joint disease. - Rheumatoid arthritis: helps control inflammatory joint symptoms in autoimmune arthritis. - Primary dysmenorrhea: lessens menstrual cramps and associated discomfort.

Nimesulide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal discomfort: mild abdominal pain or dyspepsia. - Nausea and vomiting: occasional upset stomach. - Headache: transient mild headache. - Dizziness: brief episodes of light‑headedness.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or severe liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury or reduced renal function.

Before prescribing Nimesulide, clinicians should consider several safety precautions. - Contraindications: avoid in patients with known hypersensitivity to nimesulide or other NSAIDs. - Hepatic risk: monitor liver function tests in patients with pre‑existing liver disease or prolonged therapy. - Cardiovascular caution: use cautiously in individuals with hypertension, heart failure or established cardiovascular disease. - Gastro‑intestinal protection: consider gastro‑protective agents for patients with a history of ulcer disease. - Pregnancy and lactation: avoid use during pregnancy, especially the third trimester, and during breastfeeding due to unknown safety. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Nimesulide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Corticosteroids: heightened risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, diuretics): possible reduction in antihypertensive effect. - Lithium: increased lithium serum levels. - Methotrexate: reduced renal clearance may raise methotrexate toxicity.